Agree.net – Lifestyle
Author:
Mabwell (Shanghai) Bioscience Co., Ltd.
SST001, an α-syn PET tracer from Mabwell’s incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
April 14, 2026